Saltar al contenido
MilliporeSigma

Unfolded protein response prevents blastocyst formation during preimplantation embryo development in vitro.

Fertility and sterility (2014-10-13)
Murat Basar, Idil Bozkurt, Ozlem Guzeloglu-Kayisli, Berna Sozen, Isil Tekmen, Frederick Schatz, Aydin Arici, Charles J Lockwood, Umit A Kayisli
RESUMEN

To study the effect of increased endoplasmic reticulum (ER) stress as a major nongenomic mechanism for arrested blastocyst development. Cell and animal study. The Ohio State University and Yale University. Mice. Pregnant mare serum gonadotropin and hCG were administered IP; two cell embryos were collected 48 hours after hCG administration. Blastocyst development rate. No morphological difference was detected in control versus tunicamycin- (TM) treated embryos until the blastocyst stage. On day 4 of embryonic development, TM treatment reduced blastocyst formation from 79% to 4% and induced nuclear fragmentation. TM treatment caused 2-fold and 2.6-fold increase in binding immunoglobulin protein and spliced-X-box binding protein 1 mRNA expression, respectively. By comparison, the tauroursodeoxycholic acid + TM combination reversed the effect of TM alone on blastocyst formation to near control levels. These results indicate that increased ER stress during in vitro embryo development triggers an unfolded protein response (UPR) that negatively affects blastocyst formation and suggests that activation of UPR signaling may account for low rates of blastocyst development.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Glicina, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Glicina, suitable for electrophoresis, ≥99%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Glicina, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
Glicina, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
SAFC
Glicina
USP
Glicina, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glicina, BioXtra, ≥99% (titration)
Sigma-Aldrich
Glicina, 99%, FCC
Sigma-Aldrich
Glicina, SAJ special grade, ≥99.0%
Sigma-Aldrich
Glicina, ACS reagent, ≥98.5%
Supelco
Glicina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glicina, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
Glicina, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Glicina, tested according to Ph. Eur.